Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience. If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine! We have 8 upcoming openings for the July – Dec 2018 co-op period. We will be accepting applications starting in January 2018 via NUcareers.
CaNCURE Co-op Showcase
The CaNCURE Team would like to send out a congratulations to the 8 trainees who completed their CaNCURE co-op this December! We were so proud to see all your accomplishments at our third annual CaNCURE Nanomedicine Day and to learn that for many of you, this co-op was a career-defining experience!
Omid Farokhzad, M.D.
Associate Professor of Anesthesia,
The Farokhzad group has pioneered the use of high-throughput self-assembly methods to develop novel nanomedicines. Students will focus on the design of a nanoparticle system with simultaneous diagnostic and imaging capabilities in order to help locate prostate cancer cells and study their specific characteristics.
Ciprian Catana, M.D., Ph.D.
Associate Professor in Radiology , HMS
Our laboratory seeks to improve the quantification of the PET data using the simultaneously acquired MR information in integrated MR-PET scanners. Students will have the opportunity to use advanced MR-PET methods to study the delivery, mechanism of action and effects of therapeutic agents in cancer patients.
Health Science, '19
PDT and PIT with Chemotherapy for Treatment of 3D Ovarian Cancer Nodules Under Flow and Static Conditions
Cell and Molecular Biology, '21
Use of CT Texture Analysis for Characterization and Prognostication of Incidental Adnexal Lesions
Health Science, '19
Development of Smart INCeRT Brachytherapy Spacers via PLGA and Docetaxel for Combined Chemo-Radiation Therapies in Prostate Cancer
Going on in the lab right now...
Discovering the Genetic Mechanism of Enhanced Metastatic Colonization in SMAD4 Mutant Tumors
I will be developing SMAD4 knockout cancer cell lines using mouse cells for a syngeneic study to observe the impact of immune response on enhanced metastasis in cells lacking SMAD4. Future studies will use this model to confirm the results of genetic screens meant to determine which genes downstream of SMAD4 provide this enhanced metastatic phenotype.